Liquid Biopsies – Products

Zymo Research, proudly announces the launch of its latest innovation, the Zymo-Seq™ SPLAT DNA Library Kit. This groundbreaking product is designed to deliver unparalleled precision and flexibility in DNA sequencing.

This article explores how cell-to-cell communication can be targeted for novel treatment methods.

Liquid biopsies are a minimally invasive alternative that can detect the presence of circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) as tumor biomarkers.

Strategic collaborations in molecular residual disease monitoring of cancer and product launches in ddPCR portfolio advance corporate strategy in H1 2024.

Your single solution for multimodal data​.
Uncover a true 6-base genome for unprecedented insights into current and future biological states. Access all four canonical bases and distinguish 5‑methylcytosine (5mC) and 5‑hydroxymethylcytosine (5hmC) from a single 5ng DNA sample, in a single experiment, with high accuracy.

Maximize rare variant detection with Twist's cfDNA Library Preparation Kit. Up 2X conversion yield of cfDNA libraries, high coverage libraries and robust performance, even with minimal sample input enables the confidence you value.

This whitepaper demonstrates how common methylation detection methods can be combined with Droplet Digital PCR (ddPCR) to enhance the cfDNA analysis for clinical and research applications.

New Celselect slides™ design increases efficiency of circulating tumor cell capture from liquid biopsy samples for enumeration and downstream applications.

Distinguish 5mC & 5hmC together with all 4 canonical bases to measure multiple modes of biology from a 5ng cfDNA sample in a single experiment. Identify new multimodal biomarkers to gain transformative insight into current & future states of disease.

Collaboration aims to provide researchers cutting-edge tools to enable transformational monitoring of key biomarkers in solid tissue transplants.